PA
INBX icon

Perceptive Advisors’s Inhibrx INBX Stock Holding History

Perceptive Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123M Sell
1,297,763
-144,944
-10% -$14.5M 1.85% 16
2026
Q1 		$97M Sell
1,442,707
-10,000
-0.7% -$742K 1.9% 16
2025
Q4 		$115M Buy
1,452,707
+125,000
+9% +$8.52M 2.05% 12
2025
Q3 		$44.7M Buy
1,327,707
+349,815
+36% +$8.61M 1.29% 27
2025
Q2 		$14M Sell
977,892
-86,134
-8% -$1.11M 0.52% 45
2025
Q1 		$14.9M Hold
1,064,026
– – 0.53% 42
2024
Q4 		$16.4M Hold
1,064,026
– – 0.45% 47
2024
Q3 		$16.7M Hold
1,064,026
– – 0.35% 61
2024
Q2 		$15.1M Buy
+1,064,026
New +$16.6M 0.36% 59

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Perceptive Advisors's INBX Position: Q2 2026 in Review

Perceptive Advisors reduced its Inhibrx (INBX) stake by 10% in Q2 2026, selling an estimated $14.5M and leaving 1,297,763 shares worth $123M. The position accounts for 1.85% of the portfolio, ranked #16.

Perceptive Advisors first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Perceptive Advisors held 1,297,763 shares of Inhibrx worth $123M as of Q2 2026.
  • Perceptive Advisors sold 144,944 Inhibrx shares in Q2 2026, an estimated $14.5M.
  • Inhibrx made up 1.85% of Perceptive Advisors's portfolio in Q2 2026, its #16 holding.
  • Perceptive Advisors first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.